TREATMENT OF ESSENTIAL HYPERTENSION WITH A NEW BETA-BLOCKING DRUG, TIMOLOL - EXPERIENCE WITH A BID DOSAGE REGIMEN

被引：0

作者：

PAWLOWSKI, GJ

机构：

[1] UNIV TORONTO,DEPT MED,TORONTO,ONTARIO,CANADA

[2] TORONTO GEN HOSP,DEPT FAMILY & COMMUNITY MED,TORONTO,ONTARIO,CANADA

来源：

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1977年 / 22卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：846 / 852

页数：7

共 50 条

[31] PENBUTOLOL IN HYPERTENSION - EVALUATION OF A NEW BETA-ADRENERGIC BLOCKING DRUG
BETT, JHN
WILKINSON, RK
WILLIAMS, J
RYAN, H
MEDICAL JOURNAL OF AUSTRALIA, 1980, 1 (01) : 30 - 31
[32] ACUTE HYPOTENSIVE AND RENIN-STIMULATING ACTIONS OF CAPTOPRIL BEFORE AND DURING TREATMENT WITH A BETA-BLOCKING DRUG
LEONETTI, G
BIACHINI, C
TERZOLI, L
GRADNIK, R
TUSA, M
BRAMATI, E
ZANCHETTI, A
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06): : 1564 - 1565
[33] EFFECTS OF D-TIMOLOL ON INTRAOCULAR-PRESSURE (IOP), BETA-BLOCKING ACTIVITY, AND THE DYNAMIC CHANGES OF DRUG CONCENTRATIONS IN AQUEOUS-HUMOR
ZHAO, F
JI, XC
ZHENG, YZ
JOURNAL OF OCULAR PHARMACOLOGY, 1989, 5 (04): : 271 - 279
[34] ABSOLUTE BIOAVAILABILITY STUDY IN THE DOG WITH VISACOR, A NEW CARDIOSELECTIVE BETA-BLOCKING DRUG WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY
MCAINSH, J
SMITH, RP
FERGUSON, RA
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (02) : 129 - 139
[35] TREATMENT OF ESSENTIAL ARTERIAL-HYPERTENSION WITH A NEW ALPHA AND BETA-ADRENERGIC BLOCKING-AGENT (LABETALOL)
GARCIAURIZA, V
ZAMORAHERNANDEZJAUREGUI, R
INVESTIGACION MEDICA INTERNACIONAL, 1979, 6 (02): : 184 - 187
[36] THE EFFECT OF PENBUTOLOL (HOE-893-D) - A NON-SELECTIVE BETA-BLOCKING AGENT ON ESSENTIAL ARTERIAL-HYPERTENSION
PASCUAL, ALC
SALGADO, ALC
MEDICINA CLINICA, 1983, 80 (05): : 201 - 203
[37] HEMODYNAMIC LONG-TERM EFFECTS OF A NEW BETA-ADRENOCEPTOR BLOCKING DRUG, ATENOLOL (ICI 66082), IN ESSENTIAL HYPERTENSION
LUNDJOHANSEN, P
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (03) : 445 - 451
[38] TREATMENT OF GENERALIZED ANXIETY DISORDER - COMPARISON OF A NEW BETA-BLOCKING DRUG (CGP361A), LOW-DOSE NEUROLEPTIC (FLUPENTIXOL), AND PLACEBO
BJERRUM, H
ALLERUP, P
THUNEDBORG, K
JAKOBSEN, K
BECH, P
PHARMACOPSYCHIATRY, 1992, 25 (05) : 229 - 232
[39] SPECIAL ISSUE ON - ANTIHYPERTENSIVE TREATMENT WITH DILEVALOL, A NEW BETA-BLOCKING VASODILATOR - ROUND-TABLE DISCUSSION
ROBERTSON, JIS
DOLLERY, CT
LUNDJOHANSEN, P
ZANCHETTI, A
HANSSON, L
LOUIS, W
CRUIKSHANK, J
SEEDAT, YK
BOYD, GW
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 : S42 - S45
[40] CARDIOSELECTIVE BETA-BLOCKING AGENT TENORMIN - ITS THERAPEUTIC EFFECT AND INFLUENCE ON CENTRAL, INTRACARDIAC AND REGIONAL HEMODYNAMICS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
ERINA, EV
CHARYEV, KE
OSHCHEPKOVA, EV
KARDIOLOGIYA, 1983, 23 (04) : 53 - 59

← 1 2 3 4 5 →